icon megaphone to show what's new on website

What’s new

Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. Information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products. This overview covers up to two months back. 

Filter by

Categories
Clear

Results (184)

Date Content Status
08/07/2026
Page: International arrangements
 Updated
08/07/2026
Page: New Zealand
 Updated
08/07/2026
Event: eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course (Bucharest) - October 2026
 New
08/07/2026
Medicine: Ebixa memantine
Updated
08/07/2026
Medicine: Trazimera trastuzumab
Updated
08/07/2026
Document: Meeting Summary - PCWP/HCPWP joint meeting
 New
08/07/2026
Medicine: Wyost denosumab
Updated
08/07/2026
Medicine: Mepsevii vestronidase alfa
Updated
08/07/2026
Medicine: Altuvoct efanesoctocog alfa
Updated
08/07/2026
Medicine: Tolura telmisartan
Updated
08/07/2026
Medicine: Venclyxto venetoclax
Updated
08/07/2026
Medicine: Fruzaqla fruquintinib
Updated
08/07/2026
Document: EMA risk management information day
 New
08/07/2026
Document: Clinical Trial Information System (CTIS) - Sponsor handbook
 Updated
08/07/2026
Medicine: Ritonavir Viatris (previously Ritonavir Mylan) ritonavir
Updated
08/07/2026
Document: Working arrangement for the collaboration and exchange of information on therapeutic products and medicinal products between DG SANTE/EMA and the New Zealand Ministry of Health
 New
08/07/2026
Orphan: EU/3/26/3232 - orphan designation for treatment of Wilson's disease copper metabolism disorder
New
08/07/2026
Orphan: EU/3/26/3231 - orphan designation for treatment of narcolepsy alixorexton
New
08/07/2026
Orphan: EU/3/26/3243 - orphan designation for treatment of syndromic inherited retinal dystrophies of the rod-dominant phenotype allogeneic human induced pluripotent stem cell-derived photoreceptor precursor cells
New
08/07/2026
Orphan: EU/3/26/3233 - orphan designation for treatment of KCNT1-related epilepsy (S)-N-(2-(2-Cyclopropylpyridin-4-yl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
New
08/07/2026
Orphan: EU/3/26/3235 - orphan designation for treatment of inherited retinal disease due to dysfunction in the USH2A gene antisense oligonucleotide against USH2A pre-mRNA
New
08/07/2026
Orphan: EU/3/26/3241 - orphan designation for treatment of pancreatic cancer quemliclustat
New
08/07/2026
Orphan: EU/3/26/3240 - orphan designation for treatment of peripheral T-cell lymphoma igermetostat maleate
New
08/07/2026
Orphan: EU/3/26/3239 - orphan designation for treatment of PIK3CA related overgrowth spectrum serabelisib
New
08/07/2026
PIP: EMA/PE/0000235869 - paediatric investigation plan humanised IgG1 monoclonal antibody against SEZ6, conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl]bicyclo[1.1.1]pentan-1-yl}amino)-1-oxopropan-2-yl]-3-methylbutanamide
New
08/07/2026
PIP: EMA/PE/0000239491 - paediatric investigation plan IgG1 trispecific monoclonal antibody against T-cell receptor CD3, B-cell maturation antigen and G protein-coupled receptor class C group 5 member D
New
08/07/2026
PIP: EMA/PE/0000222352 - paediatric investigation plan clostridium botulinum a, strain pm-12759 hall-a, botulin a conjugated to protein ntnh, hemagglutinin ha17, hemagglutinin ha34, hemagglutinin ha23 and hemagglutinin ha48
New
08/07/2026
PIP: EMA/PE/0000240548 - paediatric investigation plan autologous t-cells transduced with a lentiviral vector expressing a chimeric antigen receptor against bcma and gprc5d
New
07/07/2026
Page: Download website data in JSON data format
 Updated
07/07/2026
Medicine: Fluenz influenza vaccine (live attenuated, nasal)
Updated
07/07/2026
Medicine: Sarclisa isatuximab
Updated
07/07/2026
Medicine: Ixchiq Chikungunya vaccine (live)
Updated
07/07/2026
Document: List of medicines currently in PRIME scheme
 Updated
07/07/2026
Medicine: Onpattro patisiran
Updated
07/07/2026
Medicine: Abevmy bevacizumab
Updated
07/07/2026
PIP: EMA/PE/0000241119 - paediatric investigation plan (12m)-(1s,2s)-n-((63s,4s,z)-11-ethyl-12-(2-((s)-1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11h-8-oxa-2(4,2)-thiazola-1(5,3)-indola-6(1,3)-pyridazinacycloundecaphane-4-yl)-2-methylcyclopropane-1-carboxamide
New
07/07/2026
PIP: EMA/PE/0000239082 - paediatric investigation plan human (scfv)2-fab fusion protein against cd40l
New
07/07/2026
PIP: EMA/PE/0000241527 - paediatric investigation plan baxdrostat; dapagliflozin propanediol
New
07/07/2026
PIP: EMA/PE/0000241327 - paediatric investigation plan palopegteriparatide
Updated
07/07/2026
PIP: EMA/PE/0000238807 - paediatric investigation plan derivative of azabicycloheptane-carboxamide
Updated
07/07/2026
PIP: EMA/PE/0000232780 - paediatric investigation plan probenecid
New
07/07/2026
PIP: EMA/PE/0000231576 - paediatric investigation plan atrasentan
Updated
07/07/2026
PIP: EMA/PE/0000240469 - paediatric investigation plan levonorgestrel
Updated
07/07/2026
PIP: EMA/PE/0000240232 - paediatric investigation plan Brivaracetam
Updated
07/07/2026
PIP: EMA/PE/0000240971 - paediatric investigation plan rilpivirine hydrochloride; dolutegravir sodium
Updated
07/07/2026
Medicine: Telmisartan Actavis telmisartan
Updated
07/07/2026
Event: EMA workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia
 Updated
07/07/2026
News: EMA fast tracks review of a medicine for metastatic pancreatic cancer
 New
07/07/2026
PIP: EMA/PE/0000237641 - paediatric investigation plan Difelikefalin
Updated
07/07/2026
PIP: EMA/PE/0000241538 - paediatric investigation plan finerenone
Updated
07/07/2026
Event: 20th anniversary of European Medicines Agency's Patients' and Consumers' Working Party (PCWP)
 Updated
07/07/2026
Event: PCWP/HCPWP joint meeting
 Updated
07/07/2026
Medicine: Xolremdi mavorixafor
Updated
07/07/2026
Event: SPOR and XEVMPD status update webinar - Q3 2026
 Updated
07/07/2026
Event: Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system
 New
07/07/2026
Page: Qualification of novel methodologies for medicine development
 Updated
07/07/2026
Document: Qualification of novel methodologies for medicinal product development: guidance to applicants
 Updated
06/07/2026
Medicine: Calquence acalabrutinib
Updated
06/07/2026
Medicine: Tysabri natalizumab
Updated
06/07/2026
Document: Agenda of the PRAC meeting 6-9 July 2026
 New
06/07/2026
Medicine: Enhertu trastuzumab deruxtecan
Updated
06/07/2026
Document: Agenda of the HMPC meeting 6-8 July 2026
 New
06/07/2026
Document: List of signals discussed at PRAC since September 2012
 Updated
06/07/2026
Document: Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (22 May 2026 - 25 June 2026)
 New
06/07/2026
Document: Start of procedure: Extension of marketing authorisation (22 May 2026 - 25 June 2026)
 New
06/07/2026
Medicine: Alprolix eftrenonacog alfa
Updated
06/07/2026
Event: 17th Industry Standing Group (ISG) meeting
 Updated
06/07/2026
Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 8-11 June 2026 PRAC
 New
06/07/2026
Document: PRAC recommendations on signals adopted at the 8-11 June 2026 PRAC meeting
 New
03/07/2026
Medicine: Rexatilux ranibizumab
Updated
03/07/2026
PIP: EMA/PE/0000234516 - paediatric investigation plan quemliclustat
New
03/07/2026
PIP: EMA/PE/0000230610 - paediatric investigation plan cetrelimab
New
03/07/2026
PIP: EMA/PE/0000238858 - paediatric investigation plan acetylsalicylic acid; rivaroxaban
New
03/07/2026
PIP: EMA/PE/0000182225 - paediatric investigation plan eneboparatide
New
03/07/2026
PIP: EMA/PE/0000237903 - paediatric investigation plan padeliporfin di-potassium
New
03/07/2026
PIP: EMA/PE/0000239753 - paediatric investigation plan maridebart cafraglutide
New
03/07/2026
Medicine: Redemplo plozasiran
Updated
03/07/2026
Medicine: Retsevmo selpercatinib
Updated
03/07/2026
Medicine: Pyzchiva ustekinumab
Updated
03/07/2026
Medicine: Opuviz aflibercept
Updated
03/07/2026
Medicine: Cejemly sugemalimab
Updated
03/07/2026
Medicine: Kesimpta ofatumumab
Updated
03/07/2026
Medicine: Lorviqua lorlatinib
Updated
03/07/2026
PIP: EMA/PE/0000229973 - paediatric investigation plan fosigotifator sodium tromethamine
Updated
03/07/2026
Medicine: Zegalogue dasiglucagon
Updated
03/07/2026
PIP: EMA/PE/0000227014 - paediatric investigation plan baxdrostat
New
03/07/2026
Document: Abbreviations used in EMA scientific committees and Coordination Group for Mutual Recognition and Decentralised Procedures (CMD) documents, and in relation to EMA’s regulatory activities
 Updated
03/07/2026
PIP: EMA/PE/0000230592 - paediatric investigation plan gemcitabine hydrochloride
New
03/07/2026
PIP: EMA/PE/0000242035 - paediatric investigation plan puxitatug samrotecan
New
03/07/2026
PIP: EMA/PE/0000234339 - paediatric investigation plan SARS-CoV-2, spike protein, recombinant, expressed in Sf9 cells derived from Spodoptera frugiperda
Updated
03/07/2026
PIP: EMA/PE/0000237724 - paediatric investigation plan pimicotinib hydrochloride hydrate
Updated
03/07/2026
PIP: EMA/PE/0000237224 - paediatric investigation plan ocrelizumab
Updated
03/07/2026
PIP: EMA/PE/0000228372 - paediatric investigation plan borrelia outer surface protein A (OspA) serotypes (ST1-6) lipidated, fusion protein vaccine
Updated
03/07/2026
PIP: EMA/PE/0000237559 - paediatric investigation plan azilsartan medoxomil
Updated
03/07/2026
PIP: EMA/PE/0000235999 - paediatric investigation plan finerenone
Updated
03/07/2026
Event: Workshop on the use of external controls for evidence generation in regulatory decision-making
 Updated
03/07/2026
PIP: EMA/PE/0000235991 - paediatric investigation plan etimumotide; imsamotide
New
03/07/2026
PIP: EMA/PE/0000238063 - paediatric investigation plan taladegib
New
03/07/2026
PIP: EMA/PE/0000238632 - paediatric investigation plan avalglucosidase alfa
Updated
03/07/2026
Page: Variations requiring assessment (veterinary medicines)
 Updated
03/07/2026
Event: Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop on regulatory sandbox
 New
03/07/2026
PIP: EMA/PE/0000226763 - paediatric investigation plan tofacitinib citrate
Updated
03/07/2026
Event: Meeting of the HMA-EMA group focused on AI with industry stakeholders - June 2026
 New
03/07/2026
PIP: EMA/PE/0000236669 - paediatric investigation plan ritlecitinib
Updated
03/07/2026
Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
 Updated
03/07/2026
Medicine: Duvyzat givinostat
Updated
03/07/2026
PIP: EMA/PE/0000238977 - paediatric investigation plan eubacterial spores, purified from allogeneic faecal donations
Updated
03/07/2026
PIP: EMEA-003002-PIP04-23 - paediatric investigation plan avenciguat
New
03/07/2026
Page: Combination Products Operational Group: agendas and highlight reports
 Updated
03/07/2026
PIP: EMEA-002183-PIP03-23 - paediatric investigation plan imlifidase
New
03/07/2026
Medicine: NeoRecormon epoetin beta
Updated
03/07/2026
PIP: EMA/PE/0000229606 - paediatric investigation plan Deferoxamine (mesylate); histidine; tryptophan; aspartic acid; n-acetyl-histidine (monohydrate); glycine; arginine; potassium chloride; calcium chloride (dihydrate); sodium chloride; alanine; 3,4-dimethoxy-N-methylbenzohydroxamic; magnesium chloride hexahydrate; L-tryptophan; oxogluric acid; n-hydroxy-3
Updated
03/07/2026
PIP: EMA/PE/0000232894 - paediatric investigation plan adeno-associated viral vector serotype 9 containing the human MECP2 gene
New
03/07/2026
Medicine: Advagraf tacrolimus
Updated
03/07/2026
PIP: EMA/PE/0000232776 - paediatric investigation plan lunsekimig
New
03/07/2026
Event: Clinical Trials Information System (CTIS): Information day
 Updated
03/07/2026
PIP: EMA/PE/0000228536 - paediatric investigation plan enlicitide (decanoate)
Updated
03/07/2026
Shortage: Tegsedi inotersen
New
03/07/2026
Document: Medicine shortage communication (MSC): TEGSEDI® (inotersen sodium, 284 mg solution for injection in prefilled syringe): planned marketing cessation (discontinuation)
 New
03/07/2026
PIP: EMA/PE/0000238070 - paediatric investigation plan [4-(Methyl-1H-pyrazol-4-yl)-benzyl]-(6[7-(3-pyrrolidin-1-yl-propoxy)-imidazo[1,2-a]pyridin-3-yl]-pyrimidin-4-yl]-amine
New
03/07/2026
PIP: EMA/PE/0000237220 - paediatric investigation plan rezafungin acetate
Updated
03/07/2026
PIP: EMA/PE/0000236239 - paediatric investigation plan empasiprubart
New
03/07/2026
PIP: EMA/PE/0000228512 - paediatric investigation plan satralizumab
Updated
02/07/2026
PIP: EMA/PE/0000232757 - paediatric investigation plan sonelokimab
New
02/07/2026
PIP: EMA/PE/0000182928 - paediatric investigation plan propranolol hydrochloride
New
02/07/2026
PIP: EMEA-003489-PIP01-23 - paediatric investigation plan sonrotoclax
New
02/07/2026
PIP: EMEA-003489-PIP02-23 - paediatric investigation plan sonrotoclax
New
02/07/2026
PIP: EMEA-003435-PIP02-23 - paediatric investigation plan allogeneic faecal microbiota, pooled (MaaT013)
New
02/07/2026
PIP: EMA/PE/0000232774 - paediatric investigation plan 7-fluoro-1-isopropyl-3-methyl-8-(6-(3-(piperidin-1-yl)propoxy)pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one (AZD1390)
New
02/07/2026
Medicine: Aquipta atogepant
Updated
02/07/2026
Medicine: Suliqua insulin glargine; lixisenatide
Updated
02/07/2026
Medicine: Xtandi enzalutamide
Updated
02/07/2026
News: EMA steps up efforts on medicines for women’s health
 New
02/07/2026
Medicine: Xofluza baloxavir marboxil
Updated
02/07/2026
Medicine: Trimbow beclometasone; formoterol; glycopyrronium bromide
Updated
02/07/2026
Medicine: Lunsumio mosunetuzumab
Updated
02/07/2026
Medicine: Alkindi hydrocortisone
Updated
02/07/2026
Document: Declaration of interests: Silvy da Rocha Dias
 Updated
02/07/2026
Document: Declaration of interests: Virginia Rojo Guerra
 Updated
02/07/2026
PIP: EMA/PE/0000233398 - paediatric investigation plan fenfluramine hydrochloride
Updated
02/07/2026
PIP: EMA/PE/0000229605 - paediatric investigation plan ravulizumab
Updated
02/07/2026
Document: Highlight report - Combination Products Operational Group (COMBO) - In Vitro Diagnostics stream - June 2026
 New
02/07/2026
Document: Organisation chart: Information Management
 Updated
02/07/2026
Medicine: Elaprase idursulfase
Updated
01/07/2026
PIP: EMA/PE/0000235658 - paediatric investigation plan asundexian
Updated
01/07/2026
PIP: EMA/PE/0000240018 - paediatric investigation plan tezepelumab
Updated
01/07/2026
PIP: EMA/PE/0000232302 - paediatric investigation plan filgotinib maleate
Updated
01/07/2026
PIP: EMA/PE/0000224087 - paediatric investigation plan vosoritide
Updated
01/07/2026
PIP: EMA/PE/0000233864 - paediatric investigation plan Daridorexant
Updated
01/07/2026
Medicine: Ontozry cenobamate
Updated
01/07/2026
Medicine: Ondibta insulin glargine
Updated
01/07/2026
Medicine: Hetronifly serplulimab
Updated
01/07/2026
Medicine: Gotenfia golimumab
Updated
01/07/2026
Medicine: Eydenzelt aflibercept
Updated
01/07/2026
Medicine: Zypadhera olanzapine
Updated
01/07/2026
Medicine: Braftovi encorafenib
Updated
01/07/2026
Medicine: Ztalmy ganaxolone
Updated
01/07/2026
Medicine: Teriflunomide Viatris (previously Teriflunomide Mylan) teriflunomide
Updated
01/07/2026
Document: Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group
 Updated
01/07/2026
Document: Timetable: Type IB variation requiring linguistic review
 Updated
01/07/2026
Medicine: Koselugo selumetinib
Updated
01/07/2026
Medicine: Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) tenofovir disoproxil
Updated
01/07/2026
Document: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA) - Advanced therapy medicinal products (ATMPs)
 Updated
01/07/2026
Document: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA)
 Updated
01/07/2026
Medicine: Noxafil posaconazole
Updated
01/07/2026
Medicine: Wezenla ustekinumab
Updated
01/07/2026
Document: List of centrally authorised products with safety-related changes to the product information
 Updated
01/07/2026
PIP: EMA/PE/0000232765 - paediatric investigation plan sargramostim
New
01/07/2026
Document: Timetable: Post-authorisation safety study (PASS) protocols and final results
 Updated
01/07/2026
PIP: EMA/PE/0000232762 - paediatric investigation plan frexalimab
New
01/07/2026
PIP: EMA/PE/0000232758 - paediatric investigation plan remibrutinib
New
01/07/2026
PIP: EMA/PE/0000229486 - paediatric investigation plan histidine; tryptophan; aspartic acid; n-acetyl-histidine (monohydrate); glycine; alpha-ketoglutaric acid; arginine; potassium chloride; calcium chloride (dihydrate); sodium chloride; alanine; 3,4-dimethoxy-N-methylbenzohydroxamic acid (Custodiol-N); magnesium chloride hexahydrate
Updated
01/07/2026
Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
 Updated
01/07/2026
PIP: EMA/PE/0000227151 - paediatric investigation plan vidofludimus calcium
New
01/07/2026
PIP: EMA/PE/0000239193 - paediatric investigation plan hafnium oxide
New
01/07/2026
PIP: EMA/PE/0000228269 - paediatric investigation plan garetosmab
Updated
01/07/2026
PIP: EMA/PE/0000235857 - paediatric investigation plan bupivacaine
Updated
01/07/2026
Medicine: Keytruda pembrolizumab
Updated
01/07/2026
PIP: EMA/PE/0000237870 - paediatric investigation plan senaparib
New
01/07/2026
PIP: EMA/PE/0000229480 - paediatric investigation plan ianalumab
Updated
01/07/2026
Medicine: Mulpleo (previously Lusutrombopag Shionogi) lusutrombopag
Updated
01/07/2026
Medicine: Erelzi etanercept
Updated
01/07/2026
Page: Plasma master file certificates
 Updated
01/07/2026
Medicine: Stocrin efavirenz
Updated